Neuropeptide S vs Relaxin-3 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Neuropeptide S (NPS) is a 20-amino acid peptide discovered in 2004 that acts on the NPS receptor (NPSR1), a Gq/Gs-coupled GPCR with highest expression in amygdala, hypothalamus, and brainstem arousal centers. NPS produces a distinctive combination of simultaneous wakefulness prom...
Calculate Neuropeptide S dose →Relaxin-3 (also called INSL7) is the most ancient member of the insulin/relaxin superfamily and is expressed predominantly in the nucleus incertus (NI) of the brainstem, a structure implicated in stress, arousal, and hippocampal theta rhythm generation. Unlike relaxin-1 and relax...
Calculate Relaxin-3 dose →| Parameter | Neuropeptide S | Relaxin-3 |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | Preclinical | Preclinical Research |
| Half-Life | Short (minutes, CNS) | ~30-60 minutes (estimated) |
| Typical Dose | 0.1-10 nmol (ICV, animal) | 100-500 pmol ICV; 1-3 nmol/kg SC |
| Frequency | Variable | Single or twice daily (preclinical) |
| Route | Intracerebroventricular (animal research) | ICV, SC (preclinical) |
| FDA Status | Not approved | Research compound |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.